Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Diagnostic validity of space available for the spinal cord at C1 level for cervical myelopathy in patients with rheumatoid arthritis
Spine, 06/01/09
Shimizu T et al. – Data show that space available for the spinal cord (SAC) was a reliable parameter for relating myelopathy in patients with upper cervical subluxation in RA. For the purpose to screen the patients with high risk for myelopathy, 14 mm or less was recommended as a cut-off point of SAC.
Methods- An evaluation of diagnostic validity SAC at C1 level for myelopathy in RA pts
- 2 cohorts of RA pts were established:
- Group A: 140 pts with myeopathy due to upper cervical involvement selected from the database
- Group B: 99 pts with upper cervical subluxation, but not associated with myelopathy, selected from hospitalized pts
- Distributions of SAC at C1 level in both groups were evaluated
- Efficacy indexes for screening were calculated for these pts' population by previously demonstrated 2 criteria
- In addition, analysis according to receiver operating characteristic (ROC) curve was performed
- Average values of SAC were 11.1 mm in Group A and 16.5 mm in Group B
- When cut-off point for myelopathy was defined as ≤13 mm, sensitivity and specificity were 82% and 85%, respectively
- When it was defined as ≤14 mm, sensitivity increased (88%) while specificity decreased (74%)
- Accuracies by these 2 criteria were almost the same (83%, 82%)
- The left upper corner point of ROC curve was located between these 2 cut-off points
Related Articles
Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial
Clinical Therapeutics, 10/15/09
Relevance Score: 71%
Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/11/09
Relevance Score: 70%
Assistive technology for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 70%
Treatment of early RA with infliximab is beneficial
American Pharmacists Association, 11/06/09
Relevance Score: 69%
Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 69%
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Disease Activity and Cytokine Production in Mitogen-Stimulated Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis
Medical Principles and Practice, 12/14/09
Radiographic Measures to Assess Patients with Rheumatoid Arthritis: Advantages and Limitations
Rheumatic Disease Clinics of North America, 12/11/09
The morbid anatomy of "erosive osteoarthritis" of the interphalangeal finger joints. an optimized scoring system to monitor disease progression in affected joints
Annals of Rheumatic Diseases, 12/11/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
First-line DMARD choice in early rheumatoid arthritis - Do prognostic factors play a role?
Rheumatology, 12/14/09
A comparison of fatigue correlates in rheumatoid arthritis and osteoarthritis: Disparity in associations with disability, anxiety and sleep disturbance
Rheumatology, 12/14/09
Foot pain in rheumatoid arthritis prevalence, risk factors and management: an epidemiological study
Clinical Rheumatology, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


